Partners HealthCare Personalized Medicine was featured in The Boston Globe's "Game Changers" section, focused on leading innovators in Massachusetts. The Globe spoke with Heidi Rehm, director of the Laboratory for Molecular Medicine at Partners Personalized Medicine, about whole genome sequencing. Whole genome sequencing is the mapping of one's entire genome, in which deviations from the norm can indicate predispositions to disease or illness. This type of information can better help patients manage their diseases and make decisions about their care.

Read more from The Boston Globe.

Learn more about Partners HealthCare Personalized Medicine.